2019-09-05 09:26:00 Thu ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
Yale macro economist Stephen Roach draws 3 major conclusions with respect to the Chinese long-run view of the current tech trade conflict with America. First, the Chinese Xi administration would never lose legitimacy due to subpar 5.5%-to-6.3% real GDP economic growth. China retains more fiscal and monetary policy levers than global growth headwinds. Second, Chinese hawkish hardliners remain patient and methodical when they deal with external wildcards. These external wildcards include U.S. partisanship and economic policy uncertainty, Brexit trade and capital exodus, and diplomatic outrage in the South China Sea.
Third, the 5G tech titan HuaWei is a big deal and national champion for China. As China seeks to trudge on the long march toward tech supremacy, U.S. tech trade strategists should consider alternative approaches instead of the current legalistic approach to Sino-U.S. trade conflict resolution. It would be a symbolic loss of state dignity and sovereignty for China to agree to signing into law U.S. trade terms and conditions on intellectual property protection and enforcement. Alternatively, U.S. trade reps should focus on direct dispute negotiations between U.S. and Chinese tech corporations through the extant inland and international arbitration tribunals. This alternative mechanism may nevertheless favor domestic firms in China.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at [email protected] so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-06-07 04:02:05 Friday ET
The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic
2018-01-13 08:39:00 Saturday ET
The Economist digs deep into the political economy of U.S. government shutdown over 3 days in January 2018. In more than 4 years since 2014, U.S. government
2019-01-06 08:39:00 Sunday ET
President Trump signs an executive order to freeze federal employee pay in early-2019. Federal employees face furlough or work without pay due to the govern
2018-06-05 07:36:00 Tuesday ET
Just Capital issues a new report in support of the stakeholder value proposition in recent times. U.S. corporations that perform best on key priorities such
2022-02-02 10:33:00 Wednesday ET
Our proprietary alpha investment model outperforms most stock market indices from 2017 to 2022. As of early-January 2023, the U.S. Patent and Trademark O
2018-10-13 10:44:00 Saturday ET
Dow Jones tumbles 3% or 831 points while NASDAQ tanks 4%, and this negative investor sentiment rips through most European and Asian stock markets in early-O